FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo
BEIJING - Chinese regulators have approved Novartis’ Mayzent to treat relapsing multiple sclerosis in adults, the Swiss drug maker said in a statement on Saturday. Other drugs approved by China’s National Medical Products Administration to treat MS include Novartis’ Gilenya, Bayer’s Betaferon and Sanofi’s Aubagio. China has an estimated 30,000 patients with MS.
Can someone explain if this medicine heals MS patients? I mean 100%
Within a few months, Chinese will make a cheap copy of the drug and will start exporting it to Switzerland
Join the substantial illuminati and the most elite brotherhood society and live the lavish and wealth life. Are you a business, Man/woman and you want to be rich, powerful and be famous in life. CONTACT AGENT SARAH FOR MORE INFORMATION: +27827082265 WhatsApp +27679156013
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »
Source: ABC - 🏆 471. / 51 Read more »
Source: ABC - 🏆 471. / 51 Read more »